Poseida Therapeutics Presents Preliminary Results from Phase

Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit

Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Susanf Slovin , Eric Ostertag , Devon Shedlock , Nina Timberlake , Matthew Spear , Linkedin , Twitter , Research Development , Poseida Therapeutics Inc , Nasdaq , Exchange Commission , Company Booster Molecule , Research Gene Therapy , Poseida Therapeutics , High Tscm Autologous , Exceptionally Deep , Durable Responses , Castration Resistant Metastatic Prostate Cancer , Chief Executive Officer , Associate Vice Chair , Academic Administration , Memorial Sloan Kettering Cancer Center , Macrophage Activation Syndrome , Cytokine Release Syndrome , Chief Medical Officer , Hosted Conference Call , Multiple Myeloma , From Autologous , Clinical Management , Nonviral Manufacturing , Multi Product Allogeneict Cell , Site Specific Gene Editing System , Booster Molecule , Bone Marrow Transplant , Associate Director , Gene Therapy , Gene Editing System , Focus Day , Fundamental Biology , Action Beyond Oncology , Private Securities Litigation Reform Act ,